IFF
50
6
ETR
60
2
EIX
56
3
AES
64
6
VFC
17
2
AZO
48
2
FMC
43
4
BSX
69
-2
DD
56
-12
M
48
6
K
51
10
COST
66
5
HPE
12
2
ADI
61
4
BA
50
6
CTAS
55
3
HRL
38
2
MET
47
-6
MMM
30
-5
MSI
50
-2
IFF
50
6
ETR
60
2
EIX
56
3
AES
64
6
VFC
17
2
AZO
48
2
FMC
43
4
BSX
69
-2
DD
56
-12
M
48
6
K
51
10
COST
66
5
HPE
12
2
ADI
61
4
BA
50
6
CTAS
55
3
HRL
38
2
MET
47
-6
MMM
30
-5
MSI
50
-2
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Buy
62

CORT
Corcept Therapeutics

Last Price:
24.50
Seasonality Move:
4.21%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Corcept Therapeutics Price Quote

$24.50
-0.58 (-2.31%)
(Updated: May 3, 2024 at 6:45 PM ET)

Corcept Therapeutics Key Stats

Buy
62
Corcept Therapeutics (CORT) is a Buy
Day range:
$23.80 - $26.39
52-week range:
$20.84 - $34.28
Dividend yield:
0%
P/E ratio:
26.68
P/S ratio:
5.81
P/B ratio:
5.12%
Volume:
2.1M
Avg. volume:
1.1M
1-year change:
12.01%
Market cap:
$2.6B
Revenue:
$482.4M
EPS:
$0.95

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.31%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 1%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $127M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$148.7M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $90.9M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 21.92%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 18.04%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 21.92%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Data Unavailable

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 100% 13.64%
Revenue: 31.39% 3.97%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 43.60
Upside from Last Price: 73.84%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    121.4M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.3M CORT shares are owned by insiders